
NHS England has approved the routine commissioning of delayed-release mercaptamine bitartrate for eligible patients with nephropathic cystinosis, providing an additional …
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

